Clinical Research and Strategy Lead, Project Management, GeoSera LLC. John Carlos Diaz is the President and Owner of GeoSera Consulting, a Minority Business Enterprise that specializes in Clinical Research and Operations and executing Clinical Development Plans across multiple clinical trials. Prior to starting his own consulting company, John Carlos worked in Clinical Research for 10 years as a Clinical Operations Leader tasked with delivering endpoints within timelines and budgets. John Carlos has had various Clinical Operations roles with increasing levels of responsibility. Beginning at Merck in 2008, in Clinical Pharmacology through Cephalon/Teva managing phase I – IV, global, adult/pediatric clinical research from 2010 to 2015 and finally as the Clinical Operations leader for Braeburn Pharmaceuticals pipeline. Prior to entering the Clinical Research role, John Carlos was a Sr. Scientist at GSK within Drug Metabolism and Pharmacokinetics. After graduating from New York University in 2002 with a Bachelors in Biochemistry, John Carlos expanded his education base by obtaining professional certificates in Finance and Accounting from The Wharton School at the University of Pennsylvania, Clinical Research at Villanova University while finishing a Master’s degree in clinical research at George Washington University.
